Patrick G. Enright, Director, 10% Owner at Vera Therapeutics, Inc. (VERA), bought 333,333 shares at $15.00 ($5.0M) on 2022-02-10, disclosed to the SEC on 2022-04-05.
Open-market purchase of $5.0M VERA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |